Position in LRMR
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$238,500
New position
Shares Held
53,000
first reported quarter
Ownership
0.051%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026CIBC WORLD MARKET INC. holds $46,729,574 across 25 Biotechnology names. LRMR ranks #19 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GMAB |
Genmab A/S
|
488,266 | $13,100,176 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
28,078 | $12,537,950 | |
| 3 | MRNA |
Moderna, Inc.
|
69,817 | $3,546,703 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,766 | $2,909,762 | |
| 5 | RPRX |
Royalty Pharma plc
|
47,426 | $2,275,025 | |
| 6 | EXEL |
Exelixis, Inc.
|
38,204 | $1,638,569 | |
| 7 | ASND |
Ascendis Pharma A/S
|
6,381 | $1,459,526 | |
| 8 | DYN |
Dyne Therapeutics, Inc.
|
69,215 | $1,254,867 |
All Filings in LRMR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $238,500 | 53,000 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||